The subject expert committee (SEC) under India's drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday.from https://ift.tt/3Hsf43o
via IFTTT
Wednesday, November 17, 2021
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Please Leave us a comment about our content, so that we can try improve our site Quality.